Interchange Capital Partners’s Gilead Sciences GILD Stock Holding History

Interchange Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$380K	Sell	3,054 -1,106	-27%	-$155K	0.12%	176
2025 Q4	$511K	Buy	4,160 +1,049	+34%	+$127K	0.09%	194
2025 Q3	$345K	Buy	+3,111	New	+$354K	0.07%	244
2025 Q2	–	Sell	-1,888	Closed	-$212K	–	294
2025 Q1	$212K	Buy	1,888 +30	+2%	+$3.1K	0.06%	255
2024 Q4	$172K	Hold	1,858	–	–	0.06%	245
2024 Q3	$156K	Sell	1,858 -511	-22%	-$39K	0.05%	255
2024 Q2	$163K	Buy	+2,369	New	+$158K	0.06%	259
2023 Q2	–	Sell	-3,096	Closed	-$257K	–	175
2023 Q1	$257K	Buy	+3,096	New	+$256K	0.14%	168
2021 Q1	–	Sell	-2,088	Closed	-$121K	–	571
2020 Q4	$121K	Buy	+2,088	New	+$126K	0.07%	278

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Interchange Capital Partners's GILD Position: Q1 2026 in Review

Interchange Capital Partners reduced its Gilead Sciences (GILD) stake by 27% in Q1 2026, selling an estimated $155K and leaving 3,054 shares worth $380K. The position accounts for 0.12% of the portfolio, ranked #176.

Interchange Capital Partners first reported a position in GILD in Q4 2020 and has held it in 9 quarters since. The position peaked at $511K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Interchange Capital Partners held 3,054 shares of Gilead Sciences worth $380K as of Q1 2026.
Interchange Capital Partners sold 1,106 Gilead Sciences shares in Q1 2026, an estimated $155K.
Gilead Sciences made up 0.12% of Interchange Capital Partners's portfolio in Q1 2026, its #176 holding.
Interchange Capital Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 9 quarters since.
Interchange Capital Partners's Gilead Sciences position peaked at $511K in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.